| Symbol | ENLV |
|---|---|
| Name | ENLIVEX LTD. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 37 DEREH MENACHEM BEGIN ST., TEL AVIV, None None |
| Telephone | 972 (0) 3 7326616 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001596812 |
| Description | None |
New Form 424B3 - Enlivex Ltd. <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001213900-26-050966 <b>Size:</b> 156 KB
Read moreEnlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
Read moreEnlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
Read moreTASE symbol attribute type Security_Name was changed. Previous value: ZUR B13. New value: ENLIVEX.
Read moreNew Form F-3 - Enlivex Ltd. <b>Filed:</b> 2026-04-21 <b>AccNo:</b> 0001213900-26-046177 <b>Size:</b> 426 KB
Read moreEnlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
Read more